Integra LifeSciences reviews

The manufacturing of Integra's flagship product, its largest money maker, has been neglected for decades and it's starting to make a huge impact on the market. Backorders are common in the industry, however, typically resolved in a timely manner. Integra has been offline for well over 1.5 years and Hospital systems are becoming increasingly agitated with the uncertainty. The company literally had to remove its slogan of "Limit Uncertainty" because of how bad things have gotten. Their solution? Sell a different product that does NOT compare, clinically or is covered by private insurance. They seemingly only care about profit and not what's best for the patient and provider.

Since the departure of CEO Peter Arduini, this company has been sliding. A lot of churn in the C-suite. Reluctance (or cumbersome process) to hire backfills; existing employees just get reshuffled like the Titanic's deck chairs. During the pandemic employees were begged to work remotely; now they are RTW, no exceptions. Company insists on global procedures irrespective of site needs, forcing system square pegs into round holes.